[ 1 ] Merlo M, Cannatà A, Gobbo M, et al. Evolving concepts in dilated cardiomyopathy[J]. Eur J Heart Fail, 2018, 20(2):228-239.
[ 2 ] Tabish AM, Azzimato V, Alexiadis A, et al. Genetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy[J]. Biophys Rev, 2017, 9(3):207-223.
[ 3 ] McNally EM, Mestroni L. Dilated cardiomyopathy: genetic determinants and mechanisms [J]. Circ Res, 2017, 121(7): 731-748.
[ 4 ] Xu YJ, Wang ZS, Yang CX, et al. Identification and functional characterization of an ISL1 mutation predisposing to dilated cardiomyopathy[J]. J Cardiovasc Transl Res, 2019, 12(3):257-267.
[ 5 ] 李文昭, 徐迎佳, 李若谷, 等. 特发性扩张型心肌病相关GATA6基因新突变的识别[J]. 国际心血管病杂志, 2018, 45(5):34-37.
[ 6 ] Cai CL, Liang X, Shi Y, et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart[J]. Dev Cell, 2003, 5(6):877-889.
[ 7 ] Laugwitz KL, Moretti A, Lam J, et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages[J]. Nature, 2005, 433(7026):647-653.
[ 8 ] Moretti A, Caron L, Nakano A, et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification[J]. Cell, 2006, 127(6):1151-1165.
[ 9 ] Bu L, Jiang X, Martin-Puig S, et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages[J]. Nature, 2009, 460(7251):113-117.
[10] Zhou YM, Dai XY, Huang RT, et al. A novel TBX20 lossoffunction mutation contributes to adultonset dilated cardiomyopathy or congenital atrial septal defect[J]. Mol Med Rep, 2016, 14(4):3307-3314.
[11] Zhao CM, Sun B, Song HM, et al. TBX20 loss-of-function mutation associated with familial dilated cardiomyopathy[J]. Clin Chem Lab Med, 2016, 54(2):325-332.
[12] Li RG, Li L, Qiu XB, et al. GATA4 loss-of-function mutation underlies familial dilated cardiomyopathy[J]. Biochem Biophys Res Commun, 2013, 439(4):591-596.
[13] Li J, Liu WD, Yang ZL, et al. Prevalence and spectrum of GATA4 mutations associated with sporadic dilated cardiomyopathy[J]. Gene, 2014, 548(2):174-181.
[14] Yuan F, Qiu ZH, Wang XH, et al. MEF2C loss-of-function mutation associated with familial dilated cardiomyopathy[J]. Clin Chem Lab Med, 2018, 56(3):502-511.
[15] Yuan F, Qiu XB, Li RG, et al. A novel NKX2-5 loss-of-function mutation predisposes to familial dilated cardiomyopathy and arrhythmias[J]. Int J Mol Med, 2015, 35(2):478-486.
[16] Xu JH, Gu JY, Guo YH, et al. Prevalence and spectrum of NKX2-5 mutations associated with sporadic adult-onset dilated cardiomyopathy[J]. Int Heart J, 2017, 58(4):521-529.
[17] Li Y, Tian S, Lei I, et al. Transplantation of multipotent Isl1+ cardiac progenitor cells preserves infarcted heart function in mice[J]. Am J Transl Res, 2017, 9(3):1530-1542.
[18] Wang L, Meier EM, Tian S, et al. Transplantation of Isl1+ cardiac progenitor cells in small intestinal submucosa improves infarcted heart function[J]. Stem Cell Res Ther, 2017, 8(1):230.